212 related articles for article (PubMed ID: 3389746)
1. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
2. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
Zhang H; Zhao Z; Sun H
Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
[TBL] [Abstract][Full Text] [Related]
5. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
6. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
Fradet Y; Cordon-Cardo C; Whitmore WF; Melamed MR; Old LJ
Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues.
Ben-Aïssa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Braesch-Andersen S; Lagerkvist M; Lundblad ML; Gustafson H; Perlmann P
Anticancer Res; 1986; 6(2):165-70. PubMed ID: 2423013
[TBL] [Abstract][Full Text] [Related]
8. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
9. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
10. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
[TBL] [Abstract][Full Text] [Related]
12. Expression and biosynthesis of ABH-related carbohydrate antigens in normal and pathologic human urothelium.
Orntoft TF
APMIS Suppl; 1990; 17():1-34. PubMed ID: 1698403
[No Abstract] [Full Text] [Related]
13. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.
Liebert M; Wedemeyer GA; Stein JA; Washington RW; Flint A; Ren LQ; Grossman HB
Cancer Res; 1989 Dec; 49(23):6720-6. PubMed ID: 2479470
[TBL] [Abstract][Full Text] [Related]
14. Translational studies of glutathione in bladder cancer cell lines and human specimens.
Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
[TBL] [Abstract][Full Text] [Related]
15. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
17. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
[TBL] [Abstract][Full Text] [Related]
18. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
[TBL] [Abstract][Full Text] [Related]
19. Stromal and vascular invasion in an human in vitro bladder cancer model.
Booth C; Harnden P; Trejdosiewicz LK; Scriven S; Selby PJ; Southgate J
Lab Invest; 1997 Jun; 76(6):843-57. PubMed ID: 9194860
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
